Collin Kim
Vermögen: 19 929 $ am 31.07.2026
Vermögen: 19 929 $ am 31.07.2026
Sang Goo Kim is currently Director at Biocure Technology, Inc. since 2015 and Vice President at Columbia Capital, Inc. since 2008.
Former positions include Independent Director at Gravis Energy Corp.
and Independent Director at First Atlantic Nickel & Cobalt Corp.
from 2015 to 2020.
Education includes an undergraduate degree from Korea University, conferred in 1990.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 04.07.2025 | 1’992’877 ( 9.86% ) | 19 929 $ | 31.07.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| BIOCURE TECHNOLOGY INC. | Direktor/Vorstandsmitglied | 28.08.2015 |
Columbia Capital, Inc.
Columbia Capital, Inc. Investment ManagersFinance Provides investment advisory services | Corporate Officer/Principal | 01.01.2008 |
| Unternehmen | Position | Ende |
|---|---|---|
Gravis Energy Corp.
Gravis Energy Corp. Other Metals/MineralsNon-Energy Minerals Explores and develops uranium, natural resources | Direktor/Vorstandsmitglied | - |
| FIRST ATLANTIC NICKEL & COBALT CORP. | Vorstandsvorsitzender | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 5 |
|---|---|
First Atlantic Nickel Corp.
First Atlantic Nickel Corp. Other Metals/MineralsNon-Energy Minerals Engages in the acquisition, evaluation, exploration, and development of oil, gas, and mineral resources | Non-Energy Minerals |
Korea University
Korea University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Gravis Energy Corp.
Gravis Energy Corp. Other Metals/MineralsNon-Energy Minerals Explores and develops uranium, natural resources | Non-Energy Minerals |
Columbia Capital, Inc.
Columbia Capital, Inc. Investment ManagersFinance Provides investment advisory services | Finance |
Biocure Technology, Inc.
Biocure Technology, Inc. BiotechnologyHealth Technology Develops biopharmaceuticals | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen